Related Experiment Video
Updated: Jan 13, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Out-of-Pocket Health Expenditure among Patients with Skin-Related Neglected Tropical Diseases and Cutaneous
P Janaani1, Charvi Gupta1, Tarun Narang1
1Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Abstract:
Skin-related neglected tropical diseases (NTDs) represent an emerging public health and economic challenge in India. In the present prospective observational study, out-of-pocket expenditure and catastrophic health expenditure among patients diagnosed with mycetoma, subcutaneous mycoses, leishmaniasis, and cutaneous tuberculosis and nontuberculous mycobacterial (TB-NTM) infections were assessed. Using structured questionnaires, direct and indirect costs were recorded over a 6-month period. Of the 21 patients enrolled (median age 42 years), 42.9% were household heads and 61.9% lived below the international poverty line. The mean direct and indirect medical costs were $171 ± $113 and $315 ± $338, respectively, with treatment costs being the major driver of expenditure. Catastrophic health expenditure was observed in 95.2% of patients, and in nearly one-quarter of cases, health expenses exceeded the total family income. Notably, patients with TB-NTM incurred the highest individual expenses (mean $642 ± $323). The economic fallout was profound: 33.3% of patients lost employment because of disease-related disability. The study findings highlight the urgent need for enhanced public healthcare access, expanded insurance coverage-including outpatient services and essential medications-and targeted social support to reduce the crippling financial burden of skin-related NTDs in vulnerable populations. In addition, the development of standardized, country-specific diagnostic and treatment guidelines is critical for facilitating early diagnosis, timely intervention, and the prevention of disability and impoverishment in affected populations.
More Related Videos
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...